Shanghai medical shareholders have increased their holdings of 3.1 million shares

Shanghai Medicine (601607) 6th announced that March 31, April 1, shareholders in Shanghai Real (Group) Co., Ltd. to increase the shares of 3.1 million shares, accounting for the company has issued the total shares of 0.16%, overweight average price of about 19.58 yuan.　　Shanghai and its concerted action people have plans to continue to increase their holdings in the next 12 months, the cumulative increase in the proportion does not exceed the company issued the total shares of 2%. Shanghai Real and the company's controlling shareholder Shanghai Pharmaceutical (Group) Co., Ltd. constitute a consistent action-person relationship. The number of shares in the former Shanghai real-owned company is 169 million shares, accounting for 8.48% of the company's total issued shares. The number of shares held by Shanghai and its concerted action holders is 964 million shares, accounting for 48.39% of the total shares issued by the company. The number of shares in Shanghai and its concerted action holders is 967 million shares, accounting for 48.55% of the total shares issued by the company.